JP2022538222A5 - - Google Patents
Info
- Publication number
- JP2022538222A5 JP2022538222A5 JP2021576274A JP2021576274A JP2022538222A5 JP 2022538222 A5 JP2022538222 A5 JP 2022538222A5 JP 2021576274 A JP2021576274 A JP 2021576274A JP 2021576274 A JP2021576274 A JP 2021576274A JP 2022538222 A5 JP2022538222 A5 JP 2022538222A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025138827A JP2026000901A (ja) | 2019-06-26 | 2025-08-22 | Ｅｇｆｒ抗原結合断片およびそれを含む組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962866749P | 2019-06-26 | 2019-06-26 | |
| US62/866,749 | 2019-06-26 | ||
| US202063043486P | 2020-06-24 | 2020-06-24 | |
| US63/043,486 | 2020-06-24 | ||
| PCT/US2020/039682 WO2020264208A1 (en) | 2019-06-26 | 2020-06-25 | Egfr antigen binding fragments and compositions comprising same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138827A Division JP2026000901A (ja) | 2019-06-26 | 2025-08-22 | Ｅｇｆｒ抗原結合断片およびそれを含む組成物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022538222A JP2022538222A (ja) | 2022-09-01 |
| JPWO2020264208A5 JPWO2020264208A5 (https=) | 2023-07-04 |
| JP2022538222A5 true JP2022538222A5 (https=) | 2023-07-04 |
| JP7847433B2 JP7847433B2 (ja) | 2026-04-17 |
Family
ID=74060335
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576274A Active JP7847433B2 (ja) | 2019-06-26 | 2020-06-25 | Ｅｇｆｒ抗原結合断片およびそれを含む組成物 |
| JP2025138827A Pending JP2026000901A (ja) | 2019-06-26 | 2025-08-22 | Ｅｇｆｒ抗原結合断片およびそれを含む組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138827A Pending JP2026000901A (ja) | 2019-06-26 | 2025-08-22 | Ｅｇｆｒ抗原結合断片およびそれを含む組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230312729A1 (https=) |
| EP (1) | EP3990499A4 (https=) |
| JP (2) | JP7847433B2 (https=) |
| KR (1) | KR20220038356A (https=) |
| CN (1) | CN114729056A (https=) |
| AU (1) | AU2020303586A1 (https=) |
| CA (1) | CA3143522A1 (https=) |
| CL (1) | CL2021003435A1 (https=) |
| CO (1) | CO2022000404A2 (https=) |
| IL (1) | IL289100A (https=) |
| MX (1) | MX2021015882A (https=) |
| WO (1) | WO2020264208A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021023988A2 (pt) | 2019-05-31 | 2022-04-19 | Zymeworks Inc | Métodos de uso de um construto de ligação ao antígeno biespecífico que tem como alvo her2 para o tratamento de cânceres no trato biliar |
| JP2024518539A (ja) | 2020-04-04 | 2024-05-01 | ジャナックス セラピューティクス，インク． | 抗体を標的とする腫瘍によって活性化されるｅｇｆｒおよびエフェクター細胞抗原に関する組成物および方法 |
| JP2023531494A (ja) | 2020-06-25 | 2023-07-24 | アムニクス ファーマシューティカルズ， インコーポレイテッド | Ｈｅｒ－２標的化二重特異性組成物ならびにその作製および使用のための方法 |
| EP4337794A4 (en) * | 2021-05-11 | 2025-07-02 | Janux Therapeutics Inc | ANTIBODIES TARGETING EGFR AND CD3 AND THEIR USES |
| CN121426967A (zh) * | 2023-02-10 | 2026-01-30 | 阿穆尼克斯制药公司 | 靶向前列腺特异性膜抗原（psma）的组合物及其制备和使用方法 |
| EP4683718A1 (en) | 2023-04-17 | 2026-01-28 | Amunix Pharmaceuticals, Inc. | Compositions targeting epidermal growth factor receptor and methods for making and using the same |
| WO2025122957A1 (en) | 2023-12-08 | 2025-06-12 | Amunix Pharmaceuticals, Inc. | Protease activatable cytokines and methods for making and using the same |
| TW202547886A (zh) * | 2024-02-02 | 2025-12-16 | 美商黛安瑟斯醫療運營公司 | 用於治療ｃ１ｓ介導的疾病和病症的組成物、劑量和方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006301492B2 (en) * | 2005-10-11 | 2011-06-09 | Amgen Research (Munich) Gmbh | Compositions comprising cross-species-specific antibodies and uses thereof |
| JP5685535B2 (ja) * | 2008-08-18 | 2015-03-18 | ファイザー インコーポレイティッド | Ｃｃｒ２に対する抗体 |
| AU2014206217B2 (en) * | 2009-02-03 | 2015-09-17 | Amunix Pharmaceuticals, Inc. | Extended recombinant polypeptides and compositions comprising same |
| US20140155581A1 (en) * | 2011-07-06 | 2014-06-05 | Medimmune, Llc | Methods For Making Multimeric Polypeptides |
| EP2768858B1 (en) * | 2011-10-18 | 2018-08-01 | Emory University | Antibodies directed against influenza |
| US20150259420A1 (en) * | 2014-03-14 | 2015-09-17 | Novartis Ag | Antibody molecules to lag-3 and uses thereof |
| IL319047A (en) * | 2015-08-28 | 2025-04-01 | Amunix Operating Inc | Chimeric polypeptide composition and methods for its preparation and use |
| KR102162324B1 (ko) * | 2015-10-30 | 2020-10-07 | 제넨테크, 인크. | 항-HtrA1 항체 및 이의 사용 방법 |
| SG10201912565QA (en) * | 2016-09-29 | 2020-02-27 | Amgen Inc | Low-viscosity antigen binding proteins and methods of making them |
| CN106632681B (zh) * | 2016-10-11 | 2017-11-14 | 北京东方百泰生物科技有限公司 | 抗egfr和抗cd3双特异抗体及其应用 |
| WO2018140831A2 (en) * | 2017-01-27 | 2018-08-02 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| WO2019090355A1 (en) * | 2017-11-06 | 2019-05-09 | Children's National Medical Center | Cells expressing antibodies and methods of treatment using the same |
-
2020
- 2020-06-25 CA CA3143522A patent/CA3143522A1/en active Pending
- 2020-06-25 AU AU2020303586A patent/AU2020303586A1/en not_active Abandoned
- 2020-06-25 KR KR1020227002556A patent/KR20220038356A/ko active Pending
- 2020-06-25 WO PCT/US2020/039682 patent/WO2020264208A1/en not_active Ceased
- 2020-06-25 US US17/621,978 patent/US20230312729A1/en active Pending
- 2020-06-25 MX MX2021015882A patent/MX2021015882A/es unknown
- 2020-06-25 EP EP20833213.0A patent/EP3990499A4/en active Pending
- 2020-06-25 CN CN202080061211.XA patent/CN114729056A/zh active Pending
- 2020-06-25 JP JP2021576274A patent/JP7847433B2/ja active Active
-
2021
- 2021-12-19 IL IL289100A patent/IL289100A/en unknown
- 2021-12-21 CL CL2021003435A patent/CL2021003435A1/es unknown
-
2022
- 2022-01-19 CO CONC2022/0000404A patent/CO2022000404A2/es unknown
-
2025
- 2025-08-22 JP JP2025138827A patent/JP2026000901A/ja active Pending